Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma Multiforme”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02820584
What this trial is testing

A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma

Who this might be right for
de Novo Glioblastoma
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 20
Early research (Phase 1)Study completedNCT00003348
What this trial is testing

Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 56
Early research (Phase 1)Study completedNCT02871843
What this trial is testing

RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas

Who this might be right for
GlioblastomaOligodendrogliomaAnaplastic Oligodendroglioma
EpicentRx, Inc. 19
Early research (Phase 1)WithdrawnNCT01861990
What this trial is testing

Valproic Acid in Childhood Progressive Brain Tumors

Who this might be right for
Pediatric Brain TumorGliomaAnaplastic Astrocytoma+2 more
Medical University of South Carolina
Testing effectiveness (Phase 2)UnknownNCT02715297
What this trial is testing

Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Technical University of Munich 162
Testing effectiveness (Phase 2)UnknownNCT04547855
What this trial is testing

Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen

Who this might be right for
Glioblastoma
Yonggao Mou 54
Not applicableNot Yet RecruitingNCT07590726
What this trial is testing

PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors

Who this might be right for
Brain Injuries, AcuteBrain Tumor AdultBrain (Nervous System) Cancers+4 more
Rigshospitalet, Denmark 160
Testing effectiveness (Phase 2)Study completedNCT01013285
What this trial is testing

Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 70
Testing effectiveness (Phase 2)Looking for participantsNCT07318818
What this trial is testing

A Clinical Trial of P134 Cells in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma IDH Wildtype
Tasly Pharmaceutical Group Co., Ltd 26
Testing effectiveness (Phase 2)Study completedNCT01920191
What this trial is testing

Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma

Who this might be right for
CNS Tumor, Adult
University Hospital, Geneva 19
Testing effectiveness (Phase 2)Looking for participantsNCT01906385
What this trial is testing

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Who this might be right for
Glioma
Cerenome 55
Early research (Phase 1)Study completedNCT03426891
What this trial is testing

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaBrain TumorGBM
H. Lee Moffitt Cancer Center and Research Institute 21
Early research (Phase 1)Study completedNCT04842513
What this trial is testing

Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme of Brain
University Hospital Tuebingen 15
Testing effectiveness (Phase 2)Study completedNCT00004073
What this trial is testing

Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06218524
What this trial is testing

The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM

Who this might be right for
Glioblastoma Multiforme
Southern Medical University, China 200
Testing effectiveness (Phase 2)Looking for participantsNCT07356973
What this trial is testing

Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma

Who this might be right for
Glioblastoma
CRISM Therapeutics LTD 147
Not applicableUnknownNCT05772741
What this trial is testing

Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs

Who this might be right for
GlioblastomaGlioma, Malignant
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 160
Early research (Phase 1)Ended earlyNCT00508456
What this trial is testing

Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM

Who this might be right for
Glioblastoma Multiforme
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT00387894
What this trial is testing

Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult Brain Tumors
Michael Prados 6
Large-scale testing (Phase 3)UnknownNCT02623231
What this trial is testing

The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Who this might be right for
GBMDepression
Tel-Aviv Sourasky Medical Center 100
Next Page